Advertisement

Topics

MaxCyte appoints Infinity Pharma's Claudio Dansky Ullmann as its chief medical officer

05:47 EDT 25 Apr 2018 | Proactive Investors

Ullmann was most recently the senior vice president and head of clinical development at Infinity Pharmaceuticals Inc, where he oversaw all clinical development and operations

Original Article: MaxCyte appoints Infinity Pharma's Claudio Dansky Ullmann as its chief medical officer

NEXT ARTICLE

More From BioPortfolio on "MaxCyte appoints Infinity Pharma's Claudio Dansky Ullmann as its chief medical officer"

Advertisement
Quick Search
Advertisement
Advertisement